College of Life and Health Sciences, Northeastern University, Shenyang, China.
Cancer Med. 2019 May;8(5):1958-1975. doi: 10.1002/cam4.2108. Epub 2019 Apr 3.
Traditional Chinese medicine (TCM) has been practiced for thousands of years and at the present time is widely accepted as an alternative treatment for cancer. In this review, we sought to summarize the molecular and cellular mechanisms underlying the chemopreventive and therapeutic activity of TCM, especially that of the Chinese herbal medicine-derived phytochemicals curcumin, resveratrol, and berberine. Numerous genes have been reported to be involved when using TCM treatments and so we have selectively highlighted the role of a number of oncogene and tumor suppressor genes in TCM therapy. In addition, the impact of TCM treatment on DNA methylation, histone modification, and the regulation of noncoding RNAs is discussed. Furthermore, we have highlighted studies of TCM therapy that modulate the tumor microenvironment and eliminate cancer stem cells. The information compiled in this review will serve as a solid foundation to formulate hypotheses for future studies on TCM-based cancer therapy.
中医药(TCM)已有数千年的历史,目前被广泛认为是癌症的一种替代疗法。在这篇综述中,我们试图总结中医药,特别是中药衍生的植物化学物质姜黄素、白藜芦醇和小檗碱的化学预防和治疗活性的分子和细胞机制。使用中医药治疗时,有报道称涉及许多基因,因此我们选择性地强调了一些癌基因和肿瘤抑制基因在中医药治疗中的作用。此外,还讨论了中医药治疗对 DNA 甲基化、组蛋白修饰和非编码 RNA 调控的影响。此外,我们还强调了中医药治疗调节肿瘤微环境和消除癌症干细胞的研究。本综述中汇编的信息将为基于中医药的癌症治疗的未来研究制定假设提供坚实的基础。